Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 01 May 2026 for Merck & Co., Inc., €130k.
Filing timeline
BuySaleJohannes Jacobus Oosthuizen
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
Johannes Jacobus Oosthuizen: trading record in brief
Johannes Jacobus Oosthuizen, President, U.S. Market at Merck & Co., Inc., has 38 filings published from May 3, 2022 to May 1, 2026. The record is short and mixes three kinds: 17 option exercises, 14 grants and 7 market sales worth EUR 9.8 million with a median of EUR 684,075. No purchase is on file.
The largest sale, EUR 4,564,447, is from November 7, 2022. Two others follow: EUR 2,217,272 on February 2, 2024 and EUR 1,552,056 on February 6, 2026.
Activity slowed after a busy first year: 15 filings in 2022, 8 in 2023, 7 in 2024, then 4 in 2025 and 4 so far in 2026. Four filings fall in the last twelve months, one of them a sale.
At Merck & Co., Inc., Jennifer Zachary, Richard R. DeLuca and Robert M. Davis each have 5 trades within 30 days of Oosthuizen's, Steven Mizell 4, all in the same direction. Filings appear a median of 2 days after the trade.
Companies and markets linked to Johannes Jacobus Oosthuizen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
1,377 shares@ US$110.030.0001% mcap1.8% of flowCommon StockSEC:0000310158-26-000078:0
679 shares@ US$110.030.0000% mcap0.9% of flowCommon StockSEC:0000310158-26-000078:1
15,000 shares@ US$121.866121.7% of flowCommon StockSEC:0000310158-26-000040:0
5,026 shares@ US$107.406.4% of flowCommon StockSEC:0000310158-26-000020:0
8,500 shares@ US$84.08769.6% of flowCommon StockSEC:0001127602-25-005928:0
6,404 shares@ US$87.283.4% of flowCommon StockSEC:0001127602-25-004103:1
13,002 shares@ US$87.2815.3% of flowCommon StockSEC:0001127602-25-004103:0
8,664 shares@ US$97.9411.3% of flowCommon StockSEC:0001127602-25-002351:0
450 shares@ US$127.510.3% of flowCommon StockSEC:0001127602-24-014263:1
912 shares@ US$127.511.5% of flowCommon StockSEC:0001127602-24-014263:0
7,045 shares@ US$73.733.0% of flowCommon StockSEC:0001127602-24-003352:1
7,119 shares@ US$87.103.6% of flowCommon StockSEC:0001127602-24-003352:2
18,959 shares@ US$127.1813.9% of flowCommon StockSEC:0001127602-24-003352:3
6,773 shares@ US$75.366.6% of flowCommon StockSEC:0001127602-24-003352:0
3,133 shares@ US$119.434.8% of flowCommon StockSEC:0001127602-24-002036:0
2,081 shares@ US$102.38412.8% of flowCommon StockSEC:0001127602-23-027135:0
451 shares@ US$102.820.3% of flowCommon StockSEC:0001127602-23-026390:1
915 shares@ US$102.821.2% of flowCommon StockSEC:0001127602-23-026390:0
447 shares@ US$118.220.3% of flowCommon StockSEC:0001127602-23-014755:1
907 shares@ US$118.221.4% of flowCommon StockSEC:0001127602-23-014755:0
427 shares@ US$115.470.3% of flowCommon StockSEC:0001127602-23-014222:1
866 shares@ US$115.471.3% of flowCommon StockSEC:0001127602-23-014222:0
2,091 shares@ US$109.883.0% of flowCommon StockSEC:0001127602-23-002257:0
1,795 shares@ US$103.212.6% of flowCommon StockSEC:0001127602-22-025307:0
45,561 shares@ US$99.4728.6% of flowCommon StockSEC:0001127602-22-025022:4
25 of 38 declarations
